Evidence-based longevity · No hype. No pseudoscience. Just what the data shows.
IL ImmortalityLab.ai
Opinion & Editorials

GLP-1 trials re-examined for longevity endpoints - ImmortalityLab News

📅 yesterday · 👤 ImmortalityLab Desk
GL

Evidence-based brief from the Clinical Trials section of the ImmortalityLab news feed.

More in Opinion & Editorials

Get the evidence-based longevity brief

One short email a week. Papers we read, claims we graded, interventions that actually have human data. No hype. No pseudoscience. Just what the data shows.

Free. Unsubscribe any time. We will never share your email.

Browse the library